Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insect chitin synthase is a membrane-integral enzyme classified as a glycosyltransferase (family 2, EC 2.4.1.16) that catalyzes the polymerization of UDP-N-acetylglucosamine into chitin, a key structural polysaccharide in insects[1][2][3][4]. Chitin forms the scaffold of the exoskeleton (cuticle), peritrophic matrix in the gut, and tracheal linings, supporting growth, morphogenesis, and protection against environmental harm[2][4][5]. Insect genomes typically encode two primary chitin synthase isoforms: CHS1 (predominantly involved in cuticle formation) and CHS2 (involved in midgut/peritrophic matrix synthesis)[2]. The enzyme is the terminal step in the chitin biosynthetic pathway, requiring UDP-N-acetylglucosamine and divalent cations as cofactors, and operates at the plasma membrane where it synthesizes and extrudes chitin polymers into the extracellular space[1][3]. Insect chitin synthase has become an important molecular target in pesticide and insecticide development; its inhibition results in catastrophic defects in cuticle integrity and larval development, making it a selective target for disrupting insect pests and vectors[3]. Various small molecule inhibitors, including nikkomycin Z and polyoxin D, bind either to the substrate or product-binding sites, blocking enzyme function and leading to insect death, with promising applications in crop protection and disease vector control[3].
Competitive inhibition of UDP-N-acetylglucosamine binding (e.g., nikkomycin Z, polyoxin D)\nEnzyme inactivation/functional disruption leading to failed chitin polymerization and defects in cuticle/gut structure
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insect chitin synthase (CHS (sometimes further specified as CHS1 or CHS2 in literature)).